Skip to main content

Advertisement

Table 2 Biochemical, virological, serological responses and APRI change after bicyclol treatment

From: Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience

variable All patients (n = 123) Normal ALT (n = 38) Elevated ALT (n = 85)
ALT≤1 × upper limit of normal, n(%) 107 (87.0) 37 (97.4) 70 (82.4)
HBeAg loss, n(%) 11 (16.7) 2 (22.2) 9 (15.8)
HBV DNA (mean ± SD), log10IU/ml
 Pre-treatment 5.99 ± 1.76 4.43 ± 1.79 6.67 ± 1.24
 Post-treatment 5.20 ± 1.77* 4.23 ± 1.66 5.76 ± 1.59*
  1. *Compared to pretreatment level, P < 0.05